[1] |
Hong JS, Wasden C, Han DH. Introduction of digital therapeutics[J]. Computer Methods and Programs in Biomedicine, 2021, 209: 106319.
|
[2] |
王晓迪,罗晓斌,郭清. 数字疗法在慢性病健康管理中的应用及发展趋势[J]. 中华健康管理学杂志,2022,16(1):51-54.
|
[3] |
姚恒美. 全球数字疗法发展态势研究[J]. 竞争情报,2022,18(2):57-63.
|
[4] |
Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare[J]. Journal of Family Medicine and Primary Care, 2020, 9(5): 2207.
|
[5] |
Digital Therapeutics Alliance. Digital Therapeutics x-Definition -and -Core -Principles[EB/OL]. [2022-01-31].
URL
|
[6] |
动脉网. 中国数字疗法白皮书2.0:当风轻借力,一举入高空[EB/OL].[2022-01-31].
URL
|
[7] |
陈杰,李雪梅. 数字疗法的现状发展与挑战[J]. 中国数字医学,2021,16(11):94-98.
|
[8] |
术康. 国内首个"数字疗法"获NMPA批准上市[EB/OL]. [2022-01-31].
URL
|
[9] |
动脉网. 中国数字疗法白皮书2.0:从研发到商业全流程挖掘关键成功因素[EB/OL]. [2022-01-29].
URL
|
[10] |
Yin X, Han G, Zhang H, et al. A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01)[J]. Journal of Clinical and Translational Hepatology, 2020, 8(1): 1-8.
|
[11] |
Kollins SH, DeLoss DJ, Cañadas E, et al. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial[J]. The Lancet Digital Health, 2020, 2(4): e168-e178.
|
[12] |
Maricich YA, Xiong X, Gerwien R, et al. Real-world evidence for a prescription digital therapeutic to treat opioid use disorder[J]. Current Medical Research and Opinion, 2021, 37(2): 175-183.
|
[13] |
Digital Therapeutics Alliance. BlueStar® and BlueStar Rx®[EB/OL]. [2022-07-11].
URL
|
[14] |
动脉网. The Global Digital Therapeutics Industry Report 2022[EB/OL].[2022-12-02].
URL
|
[15] |
Kates MM, Beal CJ. Amblyopia[J]. JAMA, 2021, 325(4): 408.
|
[16] |
中华医学会眼科学分会斜视与小儿眼科学组,中国医师协会眼科医师分会斜视与小儿眼科学组. 中国儿童弱视防治专家共识(2021年)[J]. 中华眼科杂志,2021,57(5):336-340.
|
[17] |
National Eye Institute. Amblyopia (Lazy Eye) [EB/OL].[2022-01-31].
URL
|
[18] |
李蕾,付晶. 弱视及弱视相关双眼视功能损害治疗的新进展[J/CD]. 中华眼科医学杂志(电子版),2016,6(1):47-50.
|
[19] |
中国医学装备协会眼科专业委员会眼科检验检测学组联合中国医学装备协会眼科专业委员会眼科创新诊疗技术及装备学组. 虚拟现实与增强现实设备基于视觉健康使用的专家共识(2022)[J/OL]. 中华眼科医学杂志(电子版),2022, 12(2):125-128.
|
[20] |
Coco-Martin MB, Piñero DP, Leal-Vega L, et al. The Potential of Virtual Reality for Inducing Neuroplasticity in Children with Amblyopia[J]. Journal of Ophthalmology, 2020: 1-9.
|
[21] |
朱敏娟,邓宏伟,陶政暘,等. 双眼视知觉网络训练对弱视治疗短期视力提升效果的临床研究[J/OL]. 中华眼科医学杂志(电子版),2020,10(4):226-233.
|
[22] |
Xiao S, Gaier ED, Mazow ML, et al. Improved adherence and treatment outcomes with an engaging, personalized digital therapeutic in amblyopia[J]. Scientific Reports, 2020, 10(1): 8328.
|
[23] |
Xiao S, Angjeli E, Wu HC, et al. Randomized Controlled Trial of a Dichoptic Digital Therapeutic for Amblyopia[J]. Ophthalmology, 2022, 129(1): 77-85.
|
[24] |
Nova-Sight. CureSight amblyopia treatment[EB/OL]. [2022-12-01].
URL
|
[25] |
Wygnanski-Jaffe T, Kushner BJ, Moshkovitz A, et al. An eye-tracking-based dichoptic home treatment for amblyopia: a multicenter randomized clinical trial[J]. Ophthalmology, 2022: S0161642022008351.
|
[26] |
赵成,鄢涛. 3D/4D数字化斜弱视视功能矫治系统联合屈光矫正及遮盖疗法治疗成人弱视[J]. 国际眼科杂志,2021,21(11):2005-2007.
|
[27] |
中华人民共和国中央人民政府. 2020年我国儿童青少年总体近视率为52.7%近视低龄化问题仍突出[EB/OL]. [2022-02-01].
URL
|
[28] |
Dopavision. OUR PRODUCT: MYOPIAX®[EB/OL]. [2022-02-06].
URL
|
[29] |
Dopavision GmbH. MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation[R]. NCT04967287, clinicaltrials.gov, 2021.
|
[30] |
Schuett S, Heywood CA, Kentridge RW, et al. Rehabilitation of reading and visual exploration in visual field disorders: transfer or specificity?[J]. Brain, 2012, 135(3): 912-921.
|
[31] |
Mannan SK, Pambakian ALM, Kennard C. Compensatory strategies following visual search training in patients with homonymous hemianopia: an eye movement study.[J]. Journal of neurology, 2010, 257(11): 1812-1821.
|
[32] |
Sahraie A, Smania N, Zihl J. Use of NeuroEyeCoachTM to Improve Eye Movement Efficacy in Patients with Homonymous Visual Field Loss[J]. BioMed Research International, 2016: 5186461.
|
[33] |
Inomata T, Sung J, Nakamura M, et al. Using Medical Big Data to Develop Personalized Medicine for Dry Eye Disease[J]. Cornea, 2020, 39(1): S39-S46.
|
[34] |
Inomata T, Iwagami M, Nakamura M, et al. Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application[J]. JAMA Ophthalmology, 2020, 138(1): 58-68.
|
[35] |
Inomata T, Nakamura M, Iwagami M, et al. Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm[J]. Ophthalmology, 2019, 126(5): 766-768.
|
[36] |
赵慧,刘祖国,肖辛野,等. 非加热型湿房镜治疗干眼的临床疗效[J]. 中华眼视光学与视觉科学杂志,2014,16(9):517-521.
|
[37] |
李超,赵东卿,周丹虹,等. 干眼理疗仪治疗干眼的多中心随机对照研究[J]. 中华眼视光学与视觉科学杂志,2022,24(5):370-376.
|
[38] |
Li Z, Jiang J, Chen K, et al. Preventing corneal blindness caused by keratitis using artificial intelligence[J]. Nature Communications, 2021, 12(1): 3738.
|
[39] |
Tiwari M, Piech C, Baitemirova M, et al. Differentiation of Active Corneal Infections from Healed Scars Using Deep Learning[J]. Ophthalmology, 2022, 129(2): 139-146.
|
[40] |
Zhang Z, Wang H, Wang S, et al. Deep learning-based classification of infectious keratitis on slit-lamp images[J]. Therapeutic Advances in Chronic Disease, 2022, 13: 20406223221136071.
|
[41] |
Wang L, Chen K, Wen H, et al. Feasibility assessment of infectious keratitis depicted on slit-lamp and smartphone photographs using deep learning[J]. International Journal of Medical Informatics, 2021, 155: 104583.
|
[42] |
姚克. 我国白内障研究发展方向及面临的问题[J]. 中华眼科杂志,2015,51(4):241-244.
|
[43] |
Wu X, Huang Y, Liu Z, et al. Universal artificial intelligence platform for collaborative management of cataracts[J]. British Journal of Ophthalmology, 2019, 103(11): 1553-1560.
|
[44] |
Lin H, Li R, Liu Z, et al. Diagnostic Efficacy and Therapeutic Decision-making Capacity of an Artificial Intelligence Platform for Childhood Cataracts in Eye Clinics: A Multicentre Randomized Controlled Trial[J]. EClinicalMedicine, 2019, 9: 52-59.
|
[45] |
Zhang H, Niu K, Xiong Y, et al. Automatic cataract grading methods based on deep learning[J]. Computer Methods and Programs in Biomedicine, 2019, 182: 104978.
|
[46] |
Tham YC, Goh JHL, Anees A, et al. Detecting visually significant cataract using retinal photograph-based deep learning[J]. Nature Aging, 2022, 2(3): 264-271.
|
[47] |
Weinreb RN, Aung T, Medeiros FA. The Pathophysiology and Treatment of Glaucoma: A Review[J]. JAMA, 2014, 311(18): 1901-1911.
|
[48] |
Guo F, Li W, Zhao X, et al. A mobile app for Glaucoma diagnosis and its possible clinical applications[J]. BMC Medical Informatics and Decision Making, 2020, 20(S3): 128.
|
[49] |
Wright HR, Diamond JP. Service innovation in glaucoma management: using a web-based electronic patient record to facilitate virtual specialist supervision of a shared care glaucoma programme[J]. British Journal of Ophthalmology, 2015, 99(3): 313-317.
|
[50] |
Elson MJ, Giangiacomo A, Maa AY, et al. Early Experience With Full-scope Shared-care Teleglaucoma in Canada[J]. Journal of Glaucoma, 2022, 31(2): 79-83.
|
[51] |
Antonetti DA, Gardner TW. Diabetic Retinopathy[J]. The New England Journal of Medicine, 2012, 366(13): 1227-1239.
|
[52] |
van der Heijden AA, Abramoff MD, Verbraak F, et al. Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System[J]. Acta Ophthalmologica, 2018, 96(1): 63-68.
|
[53] |
Ipp E, Liljenquist D, Bode B, et al. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy[J]. JAMA Network Open, 2021, 4(11): e2134254.
|
[54] |
Rajalakshmi R, Subashini R, Anjana RM, et al. Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence[J]. Eye, 2018, 32(6): 1138-1144.
|
[55] |
Chakravarthy U, Goldenberg D, Young G, et al. Automated Identification of Lesion Activity in Neovascular Age-Related Macular Degeneration[J]. Ophthalmology, 2016, 123(8): 1731-1736.
|
[56] |
Keenan TDL, Goldstein M, Goldenberg D, et al. Prospective, Longitudinal Pilot Study: Daily Self-Imaging with Patient-Operated Home OCT in Neovascular Age-Related Macular Degeneration[J]. Ophthalmology Science, 2021, 1(2): 100034.
|
[57] |
Ho AC, Heier JS, Holekamp NM, et al. Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration[J]. Journal of Clinical Medicine, 2021, 10(7): 1355.
|